We are looking for 2–17 years of age to join a CD medical research study to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or moderately to severely active ulcerative colitis (including associated symptoms such as urgency to defecate, weight loss, constant need to poop, chronic fatigue and/or canker sores), consider one of our GI medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the GI medical research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrolling for a limited time.